The approvals come as COVID-19 infections increased in most states this month.
Start Your NewsReadery Pro FREE TRIAL!
| | |
#coronavirusall / Page 2
Novavax (NVAX) says the U.S., EU & Japan approved its updated COVID-19 vaccine targeting the XFG variant, marketed with Sanofi (SNY) and Takeda (TAK). Read more here.
Novavax is eligible for royalties on partner sales without its own sales infrastructure; Nuvaxovid was Japan's second-most used COVID-19 vaccine in 2025-26.
You're not imagining it: Air travel really is becoming more unpleasant. Sure, COVID-19, germophobia, and mask mandates were a short-term catalyst of bad ...
Oil companies and governments are consuming their once vast stockpiles as Iran and the United States continue to struggle for control over the Strait of Hormuz.
Exploring lost trust in institutions amid COVID-19, data centers, and surveillance debates in California.
Decision allows manufacturers to begin shipping doses, but confusion remains about insurance coverage ...
The Health secretary suggested the Pennsylvania governor is hiding something about the deaths' cause. Shapiro says he can't say more.
The shots have been approved for people 65 and older, and for younger people with underlying conditions. Others may be able to get them off label.
Pfizer & BioNTech's COMIRNATY XFG wins FDA approval for 2026-27, targeting XFG variant and high-risk ages 5+; see who's eligible now.